Camtek Ltd. (NASDAQ:CAMT) was down 4.1% during mid-day trading on Wednesday . The stock traded as low as $2.52 and last traded at $2.57, with a volume of 67,860 shares traded. The stock had previously closed at $2.68.

Several equities research analysts have recently issued reports on CAMT shares. B. Riley reissued a “buy” rating and set a $2.75 price objective on shares of Camtek in a research report on Thursday, May 5th. Zacks Investment Research downgraded shares of Camtek from a “hold” rating to a “sell” rating in a research report on Friday, May 6th. Needham & Company LLC increased their price objective on shares of Camtek from $3.00 to $4.00 and gave the stock a “buy” rating in a research report on Friday, July 22nd. Finally, TheStreet raised shares of Camtek from a “sell” rating to a “hold” rating in a research report on Thursday, July 21st. One equities research analyst has rated the stock with a hold rating and four have assigned a buy rating to the stock. The company currently has an average rating of “Buy” and an average price target of $3.42.

The company has a 50-day moving average of $2.34 and a 200 day moving average of $2.06. The firm’s market capitalization is $91.02 million.

Camtek (NASDAQ:CAMT) last posted its earnings results on Thursday, July 21st. The company reported $0.04 EPS for the quarter, topping the consensus estimate of $0.02 by $0.02. The business had revenue of $27.30 million for the quarter, compared to analyst estimates of $26.05 million. On average, equities analysts forecast that Camtek Ltd. will post $0.15 EPS for the current fiscal year.

Camtek Ltd. (Camtek) designs, develops, manufactures and markets automated solutions for production processes and for the semiconductor fabrication and printed circuit boards industries. The Company offers products-based on two core technologies: AOI and functional ink technology (FIT). The Company’s AOI systems are computerized systems that optically inspect various types of electronic product components.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.